Scribd Logo
Upload

Welcome to Scribd!

  • 40 views

    Report

    Uploaded by

    Tahsheen sarwar
    Mr. Tahsheen Sarwar, age 39, underwent a rapid RT-PCR test for SARS-CoV-2 RNA from a nasal swab sample. The test was performed at the Mumbai Airport international departure location on October 14, 2021. The test results were negative, indicating that SARS-CoV-2 virus RNA was not detected in the sample. The test has a clinical sensitivity of 98% and specificity of 99% for qualitative detection of SARS-CoV-2 RNA.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Report

    Uploaded by

    Tahsheen sarwar
    40 views1 page
    Mr. Tahsheen Sarwar, age 39, underwent a rapid RT-PCR test for SARS-CoV-2 RNA from a nasal swab sample. The test was performed at the Mumbai Airport international departure location on October 14, 2021. The test results were negative, indicating that SARS-CoV-2 virus RNA was not detected in the sample. The test has a clinical sensitivity of 98% and specificity of 99% for qualitative detection of SARS-CoV-2 RNA.

    Original Title

    Report (1) (2)

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Mr. Tahsheen Sarwar, age 39, underwent a rapid RT-PCR test for SARS-CoV-2 RNA from a nasal swab sample. The test was performed at the Mumbai Airport international departure location on October 14, 2021. The test results were negative, indicating that SARS-CoV-2 virus RNA was not detected in the sample. The test has a clinical sensitivity of 98% and specificity of 99% for qualitative detection of SARS-CoV-2 RNA.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    40 views1 page

    Report

    Uploaded by

    Tahsheen sarwar
    Mr. Tahsheen Sarwar, age 39, underwent a rapid RT-PCR test for SARS-CoV-2 RNA from a nasal swab sample. The test was performed at the Mumbai Airport international departure location on October 14, 2021. The test results were negative, indicating that SARS-CoV-2 virus RNA was not detected in the sample. The test has a clinical sensitivity of 98% and specificity of 99% for qualitative detection of SARS-CoV-2 RNA.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    of 1

    Authenticity Check

    CID : 2128729978
    Name : MR.TAHSHEEN SARWAR.T2068900
    Use a QR Code Scanner
    Age / Gender : 39 Years / Male Application To Scan the Code

    Consulting Dr. :- Collected : 14-Oct-2021 / 17:32


    Reg. Location : Mumbai Airport - International Departure Reported : 14-Oct-2021 / 18:06

    DETECTION OF SARS COVID-19 RNA VIRUS BY RAPID RT-PCR


    PARAMETER RESULT
    SARS-CoV-2 Not Detected (Negative)

    ICMR Registration No: Andheri-Mumbai- SUBUR001

    Specimen: Nasal swab in Accula buffer

    Method: Rapid RT-PCR followed by lateral flow oligo-hybridization technology.

    Intended use: It is intended for qualitative detection of SARS CoV-2 RNA from nasal swab specimen from individuals suspected of COVID-19.

    Clinical Significance: This test is an IVD approved in-vitro diagnostic test authorized for emergency use by FDA as POCT. Individuals suspected
    of COVID-19 by their healthcare provider or those who meet CDC SARS-CoV-2 clinical criteria in conjunction with epidemiological criteria can be
    tested using Rapid SARS CoV-2 RT-PCR followed by Lateral Flow oligo hybridization method.

    Clinical sensitivity: 98%; Analytical sensitivity:150 copies/ml; Specificity: 99%

    Interpretation:

    ‡ Detected: SARS CoV-2 virus RNA detected.


    ‡ Not Detected: SARS CoV-2 virus RNA not detected.
    ‡ Positive results are indicative of the presence of SARS-CoV-2 RNA.
    ‡ However, the assay cannot differentiate between live or dead virus hence, infectious status of positive patient cannot be determined.
    ‡ Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions.
    ‡ Positive & negative results must be correlated with clinical observations, patient history, and epidemiological information.
    ‡ The assay includes the internal positive & negative control for valid result interpretation of the specimen tested.
    ‡ All the positive cases will be notified to ICMR for further surveillance.

    Limitation:

    ‡ The test result variation is expected across different testing platforms due to factors such as assay sensitivity, the assay targets &
    technology.
    ‡ Optimum specimen types and timing of peak viral levels during infections caused by SARS-CoV-2 have not been determined. Collection
    of multiple specimens (Types & Time points) may be necessary in view of suspected clinical history.
    ‡ Positive results do not rule out other bacterial infection or co-infection with other viruses.
    ‡ The test is intended only for use with nasal or nasal mid-turbinate swab specimens.
    ‡ Improper collection, storage or transport of specimens may lead to false negative or invalid results.
    ‡ Collection of patient samples into media other than the supplied Accula SARS-CoV-2 Buffer (such as UTM, VTM, or saline), has been
    shown to adversely impact test performance.

    Reference: Accula SARS CoV 2 test IFU; Accula Dock Operator Guide

    * Sample processed at Molecular Diagnostics Laboratory, CPL, Andheri West


    *** End Of Report ***

    Dr.HEENA SATAM Dr.ANUSHREE GAIGAWALE


    M.Sc. Microbiology, PhD. Biochemistry M.D. (MICRO); DNB
    Molecular Biologist Microbiologist

    Page 1 of 1

    You might also like

    pFad - Phonifier reborn

    Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

    Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


    Alternative Proxies:

    Alternative Proxy

    pFad Proxy

    pFad v3 Proxy

    pFad v4 Proxy